Corporate Banner
Satellite Banner
Biomolecular Screening
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

University of Toronto Breakthrough Allows Fast, Reliable Identification of Pathogens

Published: Friday, June 21, 2013
Last Updated: Friday, June 21, 2013
Bookmark and Share
Researchers have created an electronic chip that can analyze blood and other clinical samples for infectious bacteria with record-breaking speed.

Life-threatening bacterial infections cause tens of thousands of deaths every year in North America but current methods of culturing bacteria in the lab can take days to report the specific source of the infection, and even longer to pinpoint the right antibiotic that will clear the infection.

The new technology, reported in the journal Nature Communications, can identify the pathogen in a matter of minutes, and looks for many different bacteria and drug resistance markers in parallel, allowing rapid and specific identification of infectious agents.

“Overuse of antibiotics is driving the continued emergence of drug-resistant bacteria,” said Shana Kelley (Pharmacy and Biochemistry), a senior author of the study. “A chief reason for use of ineffective or inappropriate antibiotics is the lack of a technology that rapidly offers physicians detailed information about the specific cause of the infection.”

Many infections are resistant to first-line antibiotics and there is an urgent, unmet need for technologies that can allow bacterial infections to be rapidly and specifically diagnosed, Kelley said.
The researchers developed an integrated circuit that could detect bacteria at concentrations found in patients presenting with a urinary tract infection.

“The chip reported accurately on the type of bacteria in a sample, along with whether the pathogen possessed drug resistance,” explained Chemistry Ph.D. student Brian Lam, the first author of the study.

One key to the advance was the design of an integrated circuit that could accommodate a panel of many biomarkers.

“The team discovered how to use the liquids in which biological samples are immersed as a ‘switch’ – allowing us to look separately for each biomarker in the sample in turn,” said Ted Sargent (Electrical and Computer Engineering), the other senior author of the report.

“The solution-based circuit chip rapidly and identifies and determines the antibiotic resistance of multiple pathogens – this represents a significant advance in biomolecular sensing,” said Paul S. Weiss, Kavli Chair in NanoSystems Science and Director of the California NanoSystems Institute at UCLA.

Ihor Boszko, director of business development at Xagenic, a Toronto-based in vitro diagnostics company said the breakthrough could have significant practical implications.

"This kind of highly sensitive, enzyme-free electrochemical detection technology will have tremendous utility for near patient clinical diagnostic," said Boszko. "Multiplexing of in vitro diagnostic approach adds the capability of simultaneously testing for multiple viruses or bacteria that produce similar clinical symptoms.

"It also allows for simple and cost effective manufacturing of highly multiplexed electrochemical detectors, which will certainly have a significant impact on the availability of effective diagnostic tools."


Further Information
Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,500+ scientific posters on ePosters
  • More than 3,800+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

Stem Cells: How to Predict Their Fate
Technique has potential for regenerative medicine and drug development.
Thursday, October 31, 2013
How Disease-Related Proteins Work; a "Truly Momentous" Discovery
Researchers are helping demystify an important class of proteins associated with disease.
Tuesday, July 09, 2013
Scientific News
Promising Class of New Cancer Drugs Cause Memory Loss in Mice
New findings from The Rockefeller University suggest that the original version of BET inhibitors causes molecular changes in mouse neurons, and can lead to memory loss in mice that receive it.
Electrical Control of Cancer Cells
Research led by scientists at The University of Texas Health Science Center at Houston (UTHealth) has revealed a new electrical mechanism that can control these switches.
Signature of Microbiomes Linked to Schizophrenia
Studying microbiomes in throat may help identify causes and treatments of brain disorder.
Inflammation Linked to Colon Cancer Metastasis
A new Arizona State University research study led by Biodesign Institute executive director Raymond DuBois has identified for the first time the details of how inflammation triggers colon cancer cells to spread to other organs, or metastasize.
Structural Discoveries Could Aid in Better Drug Design
Scientists have uncovered the structural details of how some proteins interact to turn two different signals into a single integrated output.
Determining the Age of Fingerprints
Watch the imprint of a tire track in soft mud, and it will slowly blur, the ridges of the pattern gradually flowing into the valleys. Researchers have tested the theory that a similar effect could be used to give forensic scientists a way to date fingerprints.
Genetic Overlapping in Multiple Autoimmune Diseases May Suggest Common Therapies
CHOP genomics expert leads analysis of genetic architecture, with eye on repurposing existing drugs.
Surprising Mechanism Behind Antibiotic-Resistant Bacteria Uncovered
Now, scientists at TSRI have discovered that the important human pathogen Staphylococcus aureus, develops resistance to this drug by “switching on” a previously uncharacterized set of genes.
Tissue Bank Pays Dividends for Brain Cancer Research
Checking what’s in the bank – the Brisbane Breast Bank, that is – has paid dividends for UQ cancer researchers.
Researchers Publish Landmark “Basket Study”
Researchers from Memorial Sloan Kettering Cancer Center (MSK) have announced results from the first published basket study, a new form of clinical trial design that explores responses to drugs based on the specific mutations in patients’ tumors rather than where their cancer originated.
SELECTBIO

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,500+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
3,800+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FREE!